Christopher J. Senner sold $1.1M of EXEL
EVP and CFO at EXELIXIS, INC.. 29,314 shares at an average of $36.14, traded Feb 24, 2025, filed Feb 26, 2025.
Score components
- +22RoleCFO
- +25Trade size$1.1M at market
- 0Share of holdings soldSold 3.6% of holdings
- +15Cluster10 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000939767-25-000033, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 24, 2025 | MOption exercise Common Stock | +29,314 | $18.80 | $551k | 808,921 | Feb 26, 2025 |
| Feb 24, 2025 | SOpen-market sale Common Stock | -29,314 | $36.14 | $1.1M | 779,607 | Feb 26, 2025 |
| Feb 24, 2025 | MOption exercise Option (right to buy)derivative | -29,314 | $0.00 | $0 | 100,000 | Feb 26, 2025 |
Related signals
Other insiders at EXELIXIS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 2Weak | EXELIXIS, INC. | Dana Aftab CSO/EVP Disc & Trans Research | $59k 1,508 shares | -0% | |
| 26Weak | EXELIXIS, INC. | Patrick J. Haley EVP, Commercial | $388k 10,000 shares | -3% | |
| 10Weak | EXELIXIS, INC. | Jack L Wyszomierski director | $331k 8,768 shares | -2% | |
| 60Notable | EXELIXIS, INC. | Julie Smith director | $2.8M 73,808 shares | -113% | |
| 55Moderate | EXELIXIS, INC. | Dana Aftab CSO/EVP Disc & Trans Research | $992k 26,987 shares | -5% | |
| 46Moderate | EXELIXIS, INC. | Bob Oliver director | $695k 18,647 shares | -36% | |
| 60Notable | EXELIXIS, INC. | Patrick J. Haley EVP, Commercial | $1.9M 52,636 shares | -15% | |
| 42Moderate | EXELIXIS, INC. | Mary C Beckerle director | $426k 12,210 shares | -29% | |
| 21Weak | EXELIXIS, INC. | Sue Gail Eckhardt director | $405k 11,568 shares | -28% | |
| 50Moderate | EXELIXIS, INC. | Maria C Freire director | $1.5M 44,114 shares | -33% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.